AIM ImmunoTech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AIM ImmunoTech generated cash of -$21,267,000, which is less than the previous year. Cash used in financing activities reached the amount of $485,000 last year. Net change in cash is therefore -$21,614,000.
Cash Flow
| 2014 | -13.91M | 2.48M | 12.78M |
|---|---|---|---|
| 2015 | -16.05M | 6.35M | 9.66M |
| 2016 | -7.38M | 2.91M | 4.75M |
| 2017 | -7.94M | 2.73M | 4.21M |
| 2018 | -10.64M | 92K | 9.43M |
| 2019 | -9.06M | -6.14M | 16.38M |
| 2020 | -10.36M | -9.16M | 56.56M |
| 2021 | -13.96M | -631K | 8.18M |
| 2022 | -16.10M | 10.98M | 80K |
| 2023 | -21.26M | -832K | 485K |
AIM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 27.05M | 32.09M | 38.50M | 1.47M | 299K | 1.41M | 2.40M | 2.11M | 2.15M | 803K |
Operating activities | ||||||||||
Net income | -28.96M | -19.44M | -19.12M | -14.4M | -9.53M | -9.81M | -8.25M | -7.50M | -15.23M | -17.45M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 238K | 256K | 775K | 733K | 792K | 878K | 1.01M | 1.30M | 1.19M | 1.14M |
Stock-based compensation expense | 243K | 954K | 1.56M | 1.03M | 853K | 0 | 571K | 410K | 181K | 326K |
| Deferred income tax benefit | 243K | 954K | 1.56M | 1.03M | 853K | 0 | 571K | 410K | 181K | 326K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 492K | -35K | 34K | 40K | 274K | -1.07M | -24K | 0 | 0 | 0 |
Inventories | 0 | 35K | 0 | 0 | -647K | 0 | 0 | -1.32M | -1.32M | 0 |
Accounts payable | 0 | 179K | -185K | -89K | -207K | 166K | 566K | -326K | -196K | 869K |
Cash generated by operating activities | -21.26M | -16.10M | -13.96M | -10.36M | -9.06M | -10.64M | -7.94M | -7.38M | -16.05M | -13.91M |
Investing activities | ||||||||||
Purchases Of Investments | -1.59M | -2.72M | -22.53M | -18.61M | -5.78M | -831K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -271K | -633K | -595K | -365K | -127K | -69K | -454K | -490K | -762K |
Acquisitions Net | 47K | 3.9M | 592K | 573K | 0 | 755K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -832K | 10.98M | -631K | -9.16M | -6.14M | 92K | 2.73M | 2.91M | 6.35M | 2.48M |
Financing activities | ||||||||||
Common Stock Issued | 485K | 80K | 13.04M | 61.24M | 15.30M | 5.07M | 2.41M | 4.74M | 9.68M | 12.81M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -4.85M | -4.68M | 1.08M | -2.22M | 1.9M | -1K | -21K | 0 |
Cash used in financing activities | 485K | 80K | 8.18M | 56.56M | 16.38M | 9.43M | 4.21M | 4.75M | 9.66M | 12.78M |
Net Change In Cash | -21.61M | -5.04M | -6.40M | 37.03M | 1.17M | -1.11M | -996K | 293K | -41K | 1.35M |
Cash at end of period | 5.43M | 27.05M | 32.09M | 38.50M | 1.47M | 299K | 1.41M | 2.40M | 2.11M | 2.15M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |